Why is end-of-life spending so high? : evidence from cancer patients
Year of publication: |
2023
|
---|---|
Authors: | Zeltzer, Dan ; Einav, Liran ; Finkelstein, Amy ; Shir, Tzvi ; Stemmer, Salomon M. ; Balicer, Ran D. |
Published in: |
The review of economics and statistics. - Cambridge, Mass. : MIT Press, ISSN 0034-6535, ZDB-ID 207962-8. - Vol. 105.2023, 3, p. 511-527
|
Subject: | Ältere Menschen | Elderly people | Krebskrankheit | Cancer | Gesundheitskosten | Health care costs | Sterblichkeit | Mortality | Israel | 2001-2013 |
-
The value of progress against cancer in the elderly
Bhattacharya, Jay, (2012)
-
The price elasticity of specialty drug use : evidence from cancer patients in medicare part D
Jung, Jeah, (2017)
-
Measuring the end of life premium in cancer using individual ex ante willingness to pay
Olofsson, Sara, (2016)
- More ...
-
Why is End-of-Life Spending So High? Evidence from Cancer Patients
Zeltzer, Dan, (2020)
-
Why is end-of-life spending so high? : evidence from cancer patients
Zeltzer, Dan, (2020)
-
Why is end-of-life spending so high? : evidence from cancer patients
Zeltzer, Dan, (2020)
- More ...